Ganesh Venkataraman

2007

In 2007, Ganesh Venkataraman earned a total compensation of $2.3M as Chief Scientific Officer, Senior Vice President, Research at Momenta Pharmaceuticals, a 10% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$92,660
Option Awards$390,147
Salary$290,928
Stock Awards$1,492,608
Other$10,949
Total$2,277,292

Venkataraman received $1.5M in stock awards, accounting for 66% of the total pay in 2007.

Venkataraman also received $92.7K in non-equity incentive plan, $390.1K in option awards, $290.9K in salary and $10.9K in other compensation.

Rankings

In 2007, Ganesh Venkataraman's compensation ranked 2,040th out of 8,700 executives tracked by ExecPay. In other words, Venkataraman earned more than 76.6% of executives.

ClassificationRankingPercentile
All
2,040
out of 8,700
77th
Division
Manufacturing
694
out of 3,314
79th
Major group
Chemicals And Allied Products
132
out of 746
82nd
Industry group
Drugs
70
out of 546
87th
Industry
Biological Products, Except Diagnostic Substances
16
out of 118
86th
Source: SEC filing on April 29, 2009.

Venkataraman's colleagues

We found four more compensation records of executives who worked with Ganesh Venkataraman at Momenta Pharmaceuticals in 2007.

2007

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2007

John Bishop

Momenta Pharmaceuticals

Senior Vice President, Pharmaceutical Sciences

2007

Steven Brugger

Momenta Pharmaceuticals

Chief Operating Officer

2007

Richard Shea

Momenta Pharmaceuticals

Chief Financial Officer

You may also like